Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Clinical trial NCT03715166 · TERMINATED
Trial details
- NCT number
- NCT03715166
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2021-09-13
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.